Skip to Content

WATSON 822 (Naproxen 375 mg)

Pill with imprint WATSON 822 is Gray, Elliptical / Oval and has been identified as Naproxen 375 mg. It is supplied by Watson Pharmaceuticals.

Naproxen is used in the treatment of back pain; pain; bursitis; ankylosing spondylitis; aseptic necrosis (and more), and belongs to the drug class Nonsteroidal anti-inflammatory drugs. Risk cannot be ruled out during pregnancy. Naproxen 375 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WATSON 822

Naproxen

Imprint:
WATSON 822
Strength:
375 mg
Color:
Gray
Size:
14.00 mm
Shape:
Elliptical / Oval
Availability:
Rx and/or OTC
Drug Class:
Nonsteroidal anti-inflammatory drugs
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Watson Pharmaceuticals
Inactive Ingredients:
croscarmellose sodium
magnesium stearate
povidone
synthetic ferric oxide black
synthetic ferric oxide red
synthetic ferric oxide yellow
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide